nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AMPK’s double-faced role in advanced stages of prostate cancer
|
Gharibpoor, Faeze |
|
|
24 |
11 |
p. 2064-2073 |
artikel |
2 |
BMI1 promotes the proliferation and inhibits autophagy of breast cancer cells by activating COPZ1
|
Chen, Shuming |
|
|
24 |
11 |
p. 2166-2174 |
artikel |
3 |
Bone loss induced by cancer treatments in breast and prostate cancer patients
|
Castañeda, Santos |
|
|
24 |
11 |
p. 2090-2106 |
artikel |
4 |
CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer
|
Lin, Chih-Yi |
|
|
24 |
11 |
p. 2120-2135 |
artikel |
5 |
Characteristics of gut microbiota in patients with gastric cancer by surgery, chemotherapy and lymph node metastasis
|
Chen, Changchang |
|
|
24 |
11 |
p. 2181-2190 |
artikel |
6 |
Colorectal cancer-derived exosomes and modulation KRAS signaling
|
Wan, Yan Hua |
|
|
24 |
11 |
p. 2074-2080 |
artikel |
7 |
Correction to: Bone loss induced by cancer treatments in breast and prostate cancer patients
|
Castañeda, Santos |
|
|
24 |
11 |
p. 2250 |
artikel |
8 |
Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer
|
Lin, Chih-Yi |
|
|
24 |
11 |
p. 2251-2253 |
artikel |
9 |
Effect of cell density on the malignant biological behavior of breast cancer by altering the subcellular localization of ANXA2 and its clinical implications
|
Chen, Jingtai |
|
|
24 |
11 |
p. 2136-2145 |
artikel |
10 |
Establishment of an acquired lorlatinib-resistant cell line of non-small cell lung cancer and its mediated resistance mechanism
|
Xie, Bo |
|
|
24 |
11 |
p. 2231-2240 |
artikel |
11 |
Excess weight and anti-PD-1 immune checkpoint inhibitor’s outcomes in non-small cell lung cancer
|
Rogado, Jacobo |
|
|
24 |
11 |
p. 2241-2249 |
artikel |
12 |
Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer
|
Vera, Ruth |
|
|
24 |
11 |
p. 2107-2119 |
artikel |
13 |
Expression pattern and clinical significance of beta 2-adrenergic receptor in oral squamous cell carcinoma: an emerging prognostic indicator and future therapeutic target
|
Krishna, Akhilesh |
|
|
24 |
11 |
p. 2191-2199 |
artikel |
14 |
IL-6 secretion of CD4+ T cells stimulated by LC3-positive extracellular vesicles in human epithelial ovarian cancer
|
Zhu, Xiu-Lin |
|
|
24 |
11 |
p. 2222-2230 |
artikel |
15 |
Long non-coding RNA signatures and related signaling pathway in T-cell acute lymphoblastic leukemia
|
Yousefi, Homayon |
|
|
24 |
11 |
p. 2081-2089 |
artikel |
16 |
MiRNAs in renal cell carcinoma
|
Miranda-Poma, Jesús |
|
|
24 |
11 |
p. 2055-2063 |
artikel |
17 |
Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy
|
Camacho, Mercedes |
|
|
24 |
11 |
p. 2175-2180 |
artikel |
18 |
Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)
|
Aparicio, Jorge |
|
|
24 |
11 |
p. 2155-2165 |
artikel |
19 |
Resveratrol inhibits TGF-β1-induced EMT in gastric cancer cells through Hippo-YAP signaling pathway
|
Deng, Lei |
|
|
24 |
11 |
p. 2210-2221 |
artikel |
20 |
The application value of CDFI and SMI combined with serological markers in distinguishing benign and malignant thyroid nodules
|
Li, Fang |
|
|
24 |
11 |
p. 2200-2209 |
artikel |
21 |
The role of liver kinase B1 in tumor progression through regulation of lipid metabolism
|
Geng, Jialu |
|
|
24 |
11 |
p. 2045-2054 |
artikel |
22 |
Timing of radiotherapy in glioblastoma based on IMRT and STUPP chemo-radiation: may be no need to rush
|
Li, Shan |
|
|
24 |
11 |
p. 2146-2154 |
artikel |